Swiss Biotech Center offers capabilities of development and manufacturing of biopharmaceuticals on mammalian expression systems up to clinical batches under cGMP quality standards. We deliver bulks of low bioburden active pharmaceutical ingredients ready for formulation and Fill&Finish.
Our state-of-the-art facility is operating with single-use technologies at each step of the process allowing an outstanding flexibility and rapidity, with a maximum batch size of 200L fed-batch.
In addition to that, Swiss Biotech Center gathers a strong network of partners allowing to embark on a full development of biopharmaceuticals, from the DNA sequence of the target API to a sterile Fill&Finish of a Drug Product.
Our state-of-the-art facility is operating with single-use technologies at each step of the process allowing an outstanding flexibility and rapidity, with a maximum batch size of 200L fed-batch.
In addition to that, Swiss Biotech Center gathers a strong network of partners allowing to embark on a full development of biopharmaceuticals, from the DNA sequence of the target API to a sterile Fill&Finish of a Drug Product.
Focus Areas
BIO DOUBLE HELIX SPONSORS
BIO HELIX SPONSORS
